Accès à distance ? S'identifier sur le proxy UCLouvain
Uterine side effects of tamoxifen: a need for systematic pretreatment screening.
Primary tabs
Document type | Article de périodique (Journal article) – Comparative Study, Journal Article |
---|---|
Access type | Accès restreint |
Publication date | 1998 |
Journal information | "Obstetrics and gynecology" - Vol. 91, no. 1, p. 40-4 (1998) |
Peer reviewed | yes |
issn | 0029-7844 |
Publication status | Publié |
Affiliations |
UCL
- Cliniques universitaires Saint-Luc UCL - MD/GYPE - Département de gynécologie, d'obstétrique et de pédiatrie |
MESH Subject | Adenocarcinoma - chemically induced - epidemiology - pathology ; Aged ; Antineoplastic Agents, Hormonal - adverse effects ; Breast Neoplasms - drug therapy ; Carcinoma in Situ - chemically induced - epidemiology - pathology ; Endometrial Hyperplasia - chemically induced - classification - epidemiology - pathology ; Endometrial Neoplasms - chemically induced - epidemiology - pathology ; Endometrium - drug effects - pathology ; Female ; Follow-Up Studies ; Humans ; Incidence ; Middle Aged ; Prospective Studies ; Tamoxifen - adverse effects ; Time Factors |
Links |
Bibliographic reference | Berlière, M ; Charles, Anne-Sophie ; Galant, Christine ; Donnez, Jacques. Uterine side effects of tamoxifen: a need for systematic pretreatment screening.. In: Obstetrics and gynecology, Vol. 91, no. 1, p. 40-4 (1998) |
---|---|
Permanent URL | http://hdl.handle.net/2078.1/24228 |